FLN catch my attention today sold my MBE (purchased @0.049 few...

First 11 Last

Share
Profile

Follow
jin12345

2,693 Posts.

34

25/07/17

15:43

Post #: 26067768
Share

Originally posted by dr.biohacker ↑

The actual freelancer side of this business is already going well, I don't expect something extraordinary. They are already generating a good revenue and re-invest that amount to the business. The only surprising announcement might come from the Escrow side of the business, which has been a work in the progress. It's a great business idea as the online sales fraud is becoming a big problem, however it is expected more time for Escrow to take off.

It is my opinion that once Escrow starts reporting a major profit, big investors will jump on board again, we will start reading bullish comments and posts written by so-called stock "experts" here and there. Then the SP will fly. Because FLN is already showing a consistent growth in the past 3 years, it is first-mover in the freelance market thus has the upper hand against its competitors, it is not a little Australian company , it has running been on the world stage with giant employer and employee database. There are hardly a handful smallcap stocks on ASX who can show numbers like FLN does. Once the Escrow starts making $$, the SP will fly for real, based on fact and value, not based on hype unlike many other little penny stock companies. The current SP will look like a joke a year later.

Expand

FLN catch my attention today
sold my MBE (purchased @0.049 few months ago) today and purchased some @70c.
looking to buy more @65c.
DYOR

FLN Price at posting: 68.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

There are more pages in this discussion • 31 more messages in this thread...

First 11 Last

Add FLN (ASX) to my watchlist

(20min delay)
Last 18.0¢		Change 0.000(0.00%)		Mkt cap ! $81.16M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	27306	18.0¢

Sellers (Offers)

Price($)	Vol.	No.
18.5¢	2150	1

View Market Depth

No.	Vol.	Price($)
1	27306	0.180
1	20000	0.175
3	51662	0.170
1	24692	0.165
1	2819	0.160

Price($)	Vol.	No.
0.185	2150	1
0.195	2100	1
0.200	71315	3
0.205	7434	2
0.210	224232	5

Last trade - 16.12pm 09/07/2024 (20 minute delay)

FLN (ASX) Chart

Day chart unavailable

FLN catch my attention today sold my MBE (purchased @0.049 few...

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

FLN catch my attention today sold my MBE (purchased @0.049 few...

Top Stories

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News